Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...
STAT13d
Pharmalittle: We’re reading about a Merck drug-label controversy, Astellas pulling an application, and more
A drug against fungal infections in cancer patients can last twice as long in people with obesity, and may make chemotherapy ...
Merck KGaA: A Continued Long-Term Upside Despite Some Lag
Merck KGaA is a healthcare/pharma company that I have been covering and investing in for about 2 years at this point. Q2 2024 ...
NBC 10 Philadelphia11d
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The company's immunotherapy drug Keytruda recorded $7.43 billion ... will end at the beginning of August. Sales of Merck's Covid antiviral pill, Lagevrio, also fell 40% to $383 million during ...
Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?
Let's look at five pharma and drug companies, PFE, LLY, ABBV, MRK and BMY, that are scheduled to release their third-quarter ...
NBC 6 South Florida11d
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
Blockbuster drugs rake in at least $1 billion in annual ... will end at the beginning of August. Sales of Merck's Covid antiviral pill, Lagevrio, also fell 40% to $383 million during the quarter.